By: Christine Mauceri, PharmD Candidate c/o 2025 On November 7th, 2024, the Food and Drug Administration (FDA) announced its proposal…
By: Amita Singh, Pharm D Candidate c/o 2025 Voxelotor, marketed under the brand name Oxbryta, was approved by the US.…
By: Rebecca Sabzanov, PharmD Candidate c/o 2026 On August 9th, 2024, the Food and Drug Administration (FDA) approved Neffy, the…
By: Ameena Qadri PharmD Candidate c/o 2027 Advancements in reproductive technology have considerably enhanced fertility treatments, with in-vitro fertilization (IVF)…
Amanda Nakhul, Biomedical Sciences c/o 2027 Reproductive rights, specifically abortion, has been a topic of contention for decades. From being…
By: Katelyn Hoosein, PharmD Candidate c/o 2025 Alzheimer’s disease (AD) is a neurodegenerative disorder with symptoms that progressively worsen…
By: Jennalynn Fung, PharmD candidate c/o 2025 Dr. Hyunah Cho, Ph.D., an Assistant Professor in the Department of Pharmaceutical Sciences,…
By Jennalynn Fung, PharmD Candidate c/o 2025 Introduction I’m a final year pharmacy student completing my Advanced Pharmacy Practice Rotations.…
By: Sariah Grant, PharmD Candidate c/o 2027 In June 2021, the Food and Drug Administration approved Novo Nordisk’s semaglutide,…
Featuring: Simkho Shimonov, PharmD Candidate c/o 2025 By: Rebecca Sabzanov, PharmD Candidate c/o 2026 Simkho Shimonov, a dedicated and diligent…